Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-01-24 @ 11:53 PM
Study NCT ID:
NCT00004058
Status:
TERMINATED
Last Update Posted:
2010-01-26
First Post:
1999-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5986; CDR0000067255
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Roger Strair, MD, PhD
Old Organization:
UMDNJ/CINJ
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |